Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01840592
Title Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk Commack New York 11725 United States Details
Memorial Sloan Kettering West Harrison Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre New York 11570 United States Details
Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow New York 10591 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field